These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 31993367)

  • 1. Inhibition of Dimethylarginine Dimethylaminohydrolase (DDAH) Enzymes as an Emerging Therapeutic Strategy to Target Angiogenesis and Vasculogenic Mimicry in Cancer.
    Hulin JA; Gubareva EA; Jarzebska N; Rodionov RN; Mangoni AA; Tommasi S
    Front Oncol; 2019; 9():1455. PubMed ID: 31993367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitors of the Hydrolytic Enzyme Dimethylarginine Dimethylaminohydrolase (DDAH): Discovery, Synthesis and Development.
    Murphy RB; Tommasi S; Lewis BC; Mangoni AA
    Molecules; 2016 May; 21(5):. PubMed ID: 27187323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new key player in VEGF-dependent angiogenesis in human hepatocellular carcinoma: dimethylarginine dimethylaminohydrolase 1.
    Buijs N; Oosterink JE; Jessup M; Schierbeek H; Stolz DB; Houdijk AP; Geller DA; van Leeuwen PA
    Angiogenesis; 2017 Nov; 20(4):557-565. PubMed ID: 28741166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene transfer of dimethylarginine dimethylaminohydrolase-2 improves the impairments of DDAH/ADMA/NOS/NO pathway in endothelial cells induced by lysophosphatidylcholine.
    Feng M; Liu L; Guo Z; Xiong Y
    Eur J Pharmacol; 2008 Apr; 584(1):49-56. PubMed ID: 18342305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small molecule inhibition of DDAH1 significantly attenuates triple negative breast cancer cell vasculogenic mimicry in vitro.
    Hulin JA; Tommasi S; Elliot D; Mangoni AA
    Biomed Pharmacother; 2019 Mar; 111():602-612. PubMed ID: 30611984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitric oxide upregulates dimethylarginine dimethylaminohydrolase-2 via cyclic GMP induction in endothelial cells.
    Sakurada M; Shichiri M; Imamura M; Azuma H; Hirata Y
    Hypertension; 2008 Nov; 52(5):903-9. PubMed ID: 18824664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dimethylarginine dimethylaminohydrolase-1 (DDAH1) is frequently upregulated in prostate cancer, and its overexpression conveys tumor growth and angiogenesis by metabolizing asymmetric dimethylarginine (ADMA).
    Reddy KRK; Dasari C; Duscharla D; Supriya B; Ram NS; Surekha MV; Kumar JM; Ummanni R
    Angiogenesis; 2018 Feb; 21(1):79-94. PubMed ID: 29150732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for dysregulation of dimethylarginine dimethylaminohydrolase I in chronic hypoxia-induced pulmonary hypertension.
    Millatt LJ; Whitley GS; Li D; Leiper JM; Siragy HM; Carey RM; Johns RA
    Circulation; 2003 Sep; 108(12):1493-8. PubMed ID: 12952847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age-related changes in ADMA-DDAH-NO pathway in rat liver subjected to partial ischemia followed by global reperfusion.
    Trocha M; Merwid-Ląd A; Chlebda-Sieragowska E; Szuba A; Pieśniewska M; Fereniec-Gołębiewska L; Kwiatkowska J; Szeląg A; Sozański T
    Exp Gerontol; 2014 Feb; 50():45-51. PubMed ID: 24269305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased (E)-4-hydroxy-2-nonenal and asymmetric dimethylarginine concentrations and decreased nitric oxide concentrations in the plasma of patients with major depression.
    Selley ML
    J Affect Disord; 2004 Jun; 80(2-3):249-56. PubMed ID: 15207938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of cytokine-induced nitric oxide synthesis by asymmetric dimethylarginine: role of dimethylarginine dimethylaminohydrolase.
    Ueda S; Kato S; Matsuoka H; Kimoto M; Okuda S; Morimatsu M; Imaizumi T
    Circ Res; 2003 Feb; 92(2):226-33. PubMed ID: 12574151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homocysteine increases the production of asymmetric dimethylarginine in cultured neurons.
    Selley ML
    J Neurosci Res; 2004 Jul; 77(1):90-3. PubMed ID: 15197741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arginine analogues incorporating carboxylate bioisosteric functions are micromolar inhibitors of human recombinant DDAH-1.
    Tommasi S; Zanato C; Lewis BC; Nair PC; Dall'Angelo S; Zanda M; Mangoni AA
    Org Biomol Chem; 2015 Dec; 13(46):11315-30. PubMed ID: 26420019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of dimethylarginine dimethylaminohydrolase reduces tissue asymmetric dimethylarginine levels and enhances angiogenesis.
    Jacobi J; Sydow K; von Degenfeld G; Zhang Y; Dayoub H; Wang B; Patterson AJ; Kimoto M; Blau HM; Cooke JP
    Circulation; 2005 Mar; 111(11):1431-8. PubMed ID: 15781754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dimethylarginine dimethylaminohydrolase regulation: a novel therapeutic target in cardiovascular disease.
    Wadham C; Mangoni AA
    Expert Opin Drug Metab Toxicol; 2009 Mar; 5(3):303-19. PubMed ID: 19331593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The DDAH/ADMA/NOS pathway.
    Tran CT; Leiper JM; Vallance P
    Atheroscler Suppl; 2003 Dec; 4(4):33-40. PubMed ID: 14664901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severely decreased activity of placental dimethylarginine dimethylaminohydrolase in pre-eclampsia.
    Anderssohn M; Maass LM; Diemert A; Lüneburg N; Atzler D; Hecher K; Böger RH
    Eur J Obstet Gynecol Reprod Biol; 2012 Apr; 161(2):152-6. PubMed ID: 22285683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of the direct effects of DDAH I on tumour angiogenesis in vivo.
    Papaevangelou E; Boult JKR; Whitley GS; Robinson SP; Howe FA
    Angiogenesis; 2018 Nov; 21(4):737-749. PubMed ID: 29721731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological activation of dimethylarginine dimethylaminohydrolase (DDAH) activity by inorganic nitrate and DDAH inhibition by N
    Bollenbach A; Tsikas D
    Amino Acids; 2019 Mar; 51(3):483-494. PubMed ID: 30536052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection of DDAH2 overexpression against homocysteine-induced impairments of DDAH/ADMA/NOS/NO pathway in endothelial cells.
    Liu LH; Guo Z; Feng M; Wu ZZ; He ZM; Xiong Y
    Cell Physiol Biochem; 2012; 30(6):1413-22. PubMed ID: 23171931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.